Magnesium and Matulane drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Magnesium (magnesium) and Matulane (procarbazine hydrochloride). Common drug interactions include nausea among females and decreased appetite among males.
The phase IV clinical study analyzes what interactions people have when they take Magnesium and Matulane. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.
What is Magnesium?
Magnesium has active ingredients of magnesium. It is often used in constipation. eHealthMe is studying from 121,144 Magnesium users. Check the latest studies of Magnesium.
What is Matulane?
Matulane has active ingredients of procarbazine hydrochloride. eHealthMe is studying from 3,440 Matulane users. Check the latest studies of Matulane.
22 people who take Magnesium and Matulane together, and have interactions are studied.
What are the common drug interactions of Magnesium and Matulane, by gender? *:
female:
- Nausea (feeling of having an urge to vomit)
- Fatigue (feeling of tiredness)
- Death
- Hypoaesthesia (reduced sense of touch or sensation)
- Vomiting
- White blood cell count decreased
male:
- Decreased appetite
- Fatigue (feeling of tiredness)
- Nausea (feeling of having an urge to vomit)
- Neuropathy peripheral (surface nerve damage)
- Platelet count decreased
- Vomiting
- Dyspnoea (difficult or laboured respiration)
- Nonspecific reaction (unspecified reaction)
- Pain
- Abdominal pain upper
What are the common drug interactions of Magnesium and Matulane, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Back pain
- Decreased appetite
- Nausea (feeling of having an urge to vomit)
- Vomiting
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Nausea (feeling of having an urge to vomit)
- Vomiting
60+:
- Death
- Nonspecific reaction (unspecified reaction)
- Hypoaesthesia (reduced sense of touch or sensation)
- Platelet count decreased
What are the existing conditions these people have? *
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 22.73%
- Brain Neoplasm Malignant (brain cancer tumour): 5 people, 22.73%
- Hodgkin's Lymphoma (cancer originating from white blood cells): 3 people, 13.64%
- Brain Neoplasm Benign (non-cancerous tumour of brain): 3 people, 13.64%
- Lymphoma (cancer that begins in immune system cells): 2 people, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Magnesium and Matulane?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Magnesium and Matulane:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Magnesium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Matulane:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Magnesium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Matulane and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on magnesium and procarbazine hydrochloride (the active ingredients of Magnesium and Matulane, respectively), and Magnesium and Matulane (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Erythromycin and Aranesp - 10 seconds ago
- Drug interactions of Methyldopa and Pravastatin Sodium - 14 seconds ago
- Could Aspirin cause Pain Exacerbated? - 19 seconds ago
- Could Actemra cause Dizziness? - 24 seconds ago
- Could Atorvastatin Calcium cause Escherichia Infection? - 35 seconds ago
- How effective is Temazepam for Sleep Disorder? - 42 seconds ago
- Could Q10 cause Nerve Injury? - 51 seconds ago
- Drug interactions of Avalide and Amlodipine Besylate - a minute ago
- Could Guaifenesin cause Weight Loss? - a minute ago
- Drug interactions of Guanfacine Hydrochloride and Calcium - a minute ago